Cognyte Software (NASDAQ:CGNT) delivered double-digit revenue growth and a sharp improvement in core operational profitability for the first quarter of fiscal 2027, capitalising on sustained global demand for its security and investigative analytics software platforms.
VersaBank (NASDAQ:VBNK) reported strong growth in its underlying lending operations for the second quarter of fiscal 2026, driven by a sustained expansion of its credit assets across North American markets.
Ollie’s Bargain Outlet Holdings (NASDAQ:OLLI) reported strong financial results for the first quarter of fiscal 2026, driven by double-digit sales growth, substantial margin expansion, and an aggressive build-out of its physical store footprint.
Macy’s (NYSE:M) reported an increase in first-quarter profitability and sales, lifted by strong luxury performance at Bloomingdale’s and positive momentum across its core turnaround properties.
MiniMed (NASDAQ:MMED) reported a 15.6% increase in fourth-quarter net sales to $837 million, closing out a record-setting fiscal year 2026 driven by strong international adoption and rising attachment rates for its continuous glucose monitoring (CGM) technologies.
Medtronic (NYSE:MDT) reported a 9.9% increase in fourth-quarter revenue to $9.8 billion, closing out its fiscal year 2026 with broad-based operational momentum across its core therapeutic portfolios.
Miami International Holdings (NYSE:MIAX) reported sharp volume expansion across its options exchanges for May 2026, driven by an influx of retail and institutional derivatives trading that lifted the firm’s total market footprint.
Parsons (NYSE:PSN) has secured a new $28 million task order from the U.S. Air Force to provide advanced software lifecycle support and system integration, reinforcing its position as a key technology provider for national security initiatives.
Thor Industries (NYSE:THO) reported a drop in fiscal third-quarter profit and revenue, prompting the recreational vehicle manufacturer to lower its full-year earnings expectations.
MannKind (NASDAQ:MNKD) achieved key clinical development milestones for its investigational lung disease therapy, pushing its dry powder formulation of nintedanib further into mid-stage clinical testing.
KBR (NYSE:KBR) announced that its Mission Technology Solutions unit has been awarded a landmark $8 billion ceiling contract by the U.S. National Science Foundation (NSF) to provide comprehensive science and engineering support for the U.S. Antarctic Program.
T1 Energy (NYSE:TE) has entered into a definitive agreement to acquire KORE Power for an aggregate enterprise value of approximately $32 million, securing a specialized foothold in the rapidly expanding utility-scale energy storage sector.
